Loading organizations...
Key people at NeuX Capital.
NeuX Capital operates as an early-stage incubator platform, specializing in the convergence of intelligence and life sciences. The firm actively identifies and cultivates innovative companies developing cross-technology solutions in these sectors, providing essential support to nascent ventures from concept to market application.
Founded in 2021 and based in Shanghai, China, NeuX Capital lists Xu Jing as a founding partner. The firm's inception reflects an insight into significant opportunities at the intersection of artificial intelligence and biological research, leveraging early-stage investments to bridge these merging technological and scientific domains.
NeuX Capital primarily supports pioneering early-stage companies and entrepreneurs within its chosen intelligence and life science sectors. Its vision aims to foster a dynamic ecosystem of interconnected technological and scientific innovations, facilitating the creation of groundbreaking solutions that will shape future advancements in health, biotechnology, and intelligent systems.
Key people at NeuX Capital.
NeuX Capital has 2 tracked investments across 2 companies. The latest tracked deal is $14.0M Seed in Atantares in July 2023.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jul 1, 2023 | Atantares | $14.0M Seed | ALI Health, Asia Green Fund | Qiming Venture Partners, Fosun Health Capital, Jiachen Capital |
| Jun 10, 2022 | Degron Therapeutics | $22.0M Series A | Jing YU | Baidu Ventures, Co WIN Ventures, Dyee Capital |